Diclofenac associated with cardiovascular health risk
A 20-year population-based study has found the use of diclofenac for pain relief is linked to an increased risk of major adverse cardiovascular events...
Government commits $25m to medicine safety research
The federal Government will invest $25 million in research to improve the safe use of medicines and medicines intervention by pharmacists.
From the President: For 25 years, accreditation has paved the way
For some, it may be hard to believe; but this month marks 25 years since the start of pharmacist accreditation for medication review in Australia.
From the President: PSA at the FIP World Congress in Seville,...
I have just returned from FIP’s World Congress of Pharmacy and Pharmaceutical Sciences in Seville, where PSA CEO Mark Kinsela, PSA Senior Pharmacist Peter...
First 100,000 Australians receive COVID-19 vaccines
More than 100,000 Australians have received their first COVID-19 vaccination, and the country now has 1.3 million doses on hand for the next rollout phases.
Case study: Uncovering Josef’s asthma flare-ups
If your patient is experiencing an increase in the frequency or severity of asthma symptoms or an increased reliance on their asthma inhaler, allergies could be the hidden cause.
